Results for this period
First quarter1 April 2026 to 30 June 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Increased sales of new passenger vehicles, sluggish sales of CA Doctor due to changes in the market and sales styles, firm demand from leasing- and used-car-related businesses, lower depreciation and amortization expenses, reduced cost of sales following a change in business policy, higher selling, general and administrative expenses including research and development expenses and personnel expenses, increased foreign exchange gains and dividend income, and the tax effect
None (no matters applicable to the note on going concern)
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2026 to 30 June 2026 |
| Net Sales | ¥428 million (YoY -0.0%) |
| Operating profit | ¥152 million (YoY -4.9%) |
| Ordinary income | ¥186 million (YoY +3.1%) |
| Profit attributable to owners of the parent | ¥138 million (YoY +19.7%) |
| Net income per share | ¥39.23 |
| Equity ratio | End of the current fiscal period 84 / End of previous period 82.5 |
| Total assets | ¥4,864 million |
| Net assets | ¥4,084 million |
| Full-year earnings forecast | Net Sales ¥1,770 million (YoY +2.1%) / Operating profit ¥619 million (YoY +2.5%) / Ordinary income ¥664 million (YoY +3.9%) / Net income ¥407 million (YoY +37.0%) |
| Annual Dividend Forecast | ¥38 → ¥38（0.0%） |
| Depreciation and amortization | ¥19,716 thousand |
| Disclosure regarding the going concern assumption | None (no matters applicable to the note on going concern) |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New — companies (Company name: —) / Excluded — companies (Company name: —) |
| Availability of Supplementary Financial Results Materials | No |
| Availability of Financial Results Briefing | Whether applicable No / Subject person Not disclosed |
| Issued Shares at Period-End | 3,570,000 Shares |
| Treasury Shares at Period-End | 41,914 Shares |
| Factors Behind Changes in Business Performance | Increased sales of new passenger vehicles, sluggish sales of CA Doctor due to changes in the market and sales styles, firm demand from leasing- and used-car-related businesses, lower depreciation and amortization expenses, reduced cost of sales following a change in business policy, higher selling, general and administrative expenses including research and development expenses and personnel expenses, increased foreign exchange gains and dividend income, and the tax effect |
Items this document does not state (15)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue was broadly in line with the same period of the previous fiscal year. Although sales of the core product “CA Doctor” fell below the level of the same period of the previous fiscal year, demand from leasing-related and used-car-related businesses remained firm. Operating profit declined despite lower depreciation and amortization expenses and a reduction in the cost of sales following a change in business policy, as selling, general and administrative expenses increased due to higher research and development expenses and personnel expenses in anticipation of new businesses. Ordinary profit increased due to foreign exchange gains and higher dividend income, while net income increased due to the tax effect.